LENSAR Inc LNSR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:04 PM EDT
4.20quote price arrow up+0.23 (+5.79%)
Volume
33,682
52 week range
1.80 - 5.30
Loading...
  • Open3.99
  • Day High4.33
  • Day Low3.99
  • Prev Close3.97
  • 52 Week High5.30
  • 52 Week High Date03/04/24
  • 52 Week Low1.80
  • 52 Week Low Date11/08/23

Key Stats

  • Market Cap47.865M
  • Shares Out11.40M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change19.65

KEY STATS

  • Open3.99
  • Day High4.33
  • Day Low3.99
  • Prev Close3.97
  • 52 Week High5.30
  • 52 Week High Date03/04/24
  • 52 Week Low1.80
  • 52 Week Low Date11/08/23
  • Market Cap47.865M
  • Shares Out11.40M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change19.65

RATIOS/PROFITABILITY

  • EPS (TTM)-1.34
  • P/E (TTM)-3.13
  • Fwd P/E (NTM)-3.78
  • EBITDA (TTM)-8.714M
  • ROE (TTM)-38.14%
  • Revenue (TTM)42.164M
  • Gross Margin (TTM)50.06%
  • Net Margin (TTM)-34.11%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On LENSAR Inc

 

Profile

MORE
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to...
William Link Ph.D.
Independent Chairman of the Board
Nicholas Curtis
Chief Executive Officer, Director
Alan Connaughton
Chief Operating Officer
Thomas Staab II
Chief Financial Officer, Secretary
Address
2800 Discovery Drive, Suite 100
Orlando, FL
32826
United States

Top Peers

SYMBOLLASTCHG%CHG
IRIX
IRIDEX Corp
2.69-0.39-12.66%
APYX
Apyx Medical Corp
1.42+0.01+0.71%
PDEX
Pro-Dex Inc
19.56+0.23+1.19%
CTSO
Cytosorbents Corp
0.8312-0.0004-0.0481%
BNGO
Bionano Genomics Inc
1.18+0.06+5.86%